Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ADH1B | P00325 | 2/20 | 0.44 |
| ▸ | ADH1C | P00326 | 2/20 | 0.44 |
| ▸ | ADH1A | P07327 | 2/20 | 0.44 |
| ▸ | ADH4 | P08319 | 2/20 | 0.44 |
| ▸ | ADH7 | P40394 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7733731 | 1.00 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL9263689 | 1.00 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL3850489 | 1.00 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL3847166 | 1.00 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL2961306 | 1.00 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL276625 | 0.98 | LMNA (0.43) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL5076605 | 0.96 | LMNA (0.50) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL16023957 | 0.96 | LMNA (0.50) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL5075482 | 0.96 | LMNA (0.50) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL22465774 | 0.96 | LMNA (0.50) | LMNATSHRADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705270-A1 | HYDROFORMYLATION PROCESS | Dow Technology Investments LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4634148-A1 | PROCESS TO MINIMIZE POLYPHOSPHINE USAGE BY MAKING USE OF DEGRADATION PRODUCTS | Dow Technology Investments LLC (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4608553-A1 | HETEROGENEOUS CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4448171-B1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-4448170-B1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| US-20250128245-A1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-04-24 | — | — | US | disclosed |
| US-12246310-B2 | Processes for recovery of rhodium from a hydroformylation process | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-03-11 | — | — | US | disclosed |
| WO-2025029349-A1 | HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-02-06 | — | — | WO | disclosed |
| EP-4054762-B1 | PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-18 | — | — | EP | disclosed |
| US-20240399349-A1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-05 | — | — | US | disclosed |
| US-5237106-A | Treating with propargyl alcohol and carboxylic acid, removing acid | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0552797-A1 | Reactivation of hydroformylation catalysts | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-07-28 | — | — | EP | disclosed |
| EP-0389617-B1 | TREATMENT OF RHODIUM CATALYSTS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5180854-A | Separation of aldehyde from rhodium phosphorous ligand with solvent | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-01-19 | — | — | US | disclosed |
| EP-0357997-B1 | REACTIVATION OF HYDROFORMYLATION CATALYSTS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) | 1992-11-25 | — | — | EP | disclosed |
| EP-0389617-A1 | TREATMENT OF RHODIUM CATALYSTS. | UNION CARBIDE CHEM PLASTIC (US) | 1990-10-03 | — | — | EP | disclosed |
| US-4929767-A | PRETREATING AN ORGANIC SOLUTION OF A DEACTIVATED RHODIUM-PHOSPHINE COMPLEX TO IMPROVE RHODIUM EXTRACTABILITY INTO AN AQUEOUS SOLUTION; REUSE | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) | 1990-05-29 | — | — | US | disclosed |
| EP-0357997-A1 | Reactivation of hydroformylation catalysts | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) | 1990-03-14 | — | — | EP | disclosed |
| EP-0350922-A2 | Process for catalyst-aldehyde product separation | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) | 1990-01-17 | — | — | EP | disclosed |
| US-4861918-A | RHODIUM-TERITARY ORGANOPHOSPHINE COMPLEX | UNION CARBIDE CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250128245-A1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | C1R, M6PR, FOLR1 | LMNA 823/4885TSHR 359/4885ADH1B 2359/4885 |
| US-20240399349-A1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | M6PR, KRAS, C1R | LMNA 259/4885TSHR 3827/4885ADH1B 1496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.